Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  EOS Imaging    EOSI   FR0011191766

EOS IMAGING

(EOSI)
  Report  
Delayed Quote. Delayed Euronext Paris - 08/16 11:35:13 am
0.966 EUR   +0.52%
2018EOS IMAGING : reports third quarter 2018 sales
PU
2018EOS IMAGING : 3rd quarter earnings
CO
2018EOS IMAGING : Half-year results
CO
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

EOS imaging : announces first system installation within Asklepios Private Hospital Group in Germany

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/21/2018 | 03:01pm EDT

EOS imaging ANNOUNCES FIRST SYSTEM INSTALLATION WITHIN ASKLEPIOS PRIVATE

HOSPITAL GROUP IN GERMANY

The second largest private hospital group in Germany adopts EOS® for its Asklepios Paulinen Hospital

Paris, February 21, 2018 - 6:00 pm (CET) - EOS imaging(Euronext, FR0011191766 - EOSI - Eligible PEA - PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced the first installation of an EOS® system within the Asklepios Hospital Group, the second largest private hospital network in Germany. The EOS system is available at the Asklepios Paulinen Hospital, enabling 3D full-body imaging at a low-dose of radiation, and reinforcing the hospital's mission as a "Center of Excellence" for back disorders and treatment. The Asklepios Paulinen Hospital hosted a ceremony to celebrate the installation and introduce the community to the EOS system on February 21, 3:00 - 5:00 pm CET.

The Asklepios Paulinen Hospital is a general hospital with 316 beds located in Wiesbaden, Germany that specializes in state-of-the-art methods for improved patient care. In order to diagnose and treat patients in an interdisciplinary manner, it established several specialized medical centers including spinal surgery and orthopedics. With the installation of the EOS system, the spine and orthopedic team has taken another step towards an integrative "Center of Excellence" for the diagnosis and treatment of back disorders. The new device represents a major advance in diagnostics, the subsequent treatment planning and the treatment control of malpositions and deformities of the musculoskeletal system.

"I am thrilled with the new system, which opens up a whole new range of diagnostic options, including more than 100 3D clinical parameters that provide information on the spine's angular and axial relationships with unprecedented precision. Particularly for patients with deformities like scoliosis, the Micro Dose option is a clear advantage, allowing us to take pictures with minimal radiation while maintaining excellent image quality,"commented Professor Dr. Thomas Niemeyer, Head of the Spine Surgery Department.

"We are pleased to expand our presence in Germany with this installation,"commented Marie Meynadier, Chief Executive Officer of EOS imaging. "The Asklepios Hospital Group is committed to advancing the orthopedic standard of care, as evidenced by building a Center of Excellence for the diagnosis and treatment of back disorders at the Asklepios Paulinen Hospital. We look forward to our technology contributing to this commitment."

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopaedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States (FDA), Japan and the European Union (EC). The Group posted 2017 sales of €37.1 million and employs 152 people at December 2017. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.

EOS imaging has been selected to integrate the EnterNext © PEA - PME 150 index, composed of 150 French, listed companies on the Euronext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris ISIN: FR0011191766 - Ticker: EOSI

Contacts:

EOS imagingCFO

Pierre Schwich

Ph: +33 (0)1 55 25 61 24investors@eos-imaging.com

The Ruth Group (US)

Press relations Joanna Zimmerman Ph: 646-536-7006jzimmerman@theruthgroup.com

EOS imaging SA published this content on 21 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 February 2018 20:00:02 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EOS IMAGING
2018EOS IMAGING : reports third quarter 2018 sales
PU
2018EOS IMAGING : 3rd quarter earnings
CO
2018EOS IMAGING : Half-year results
CO
2018EOS IMAGING SA : half-yearly earnings release
2018EOS IMAGING : 2nd quarter earnings
CO
2018EOS IMAGING : Half-year report
CO
2018EOS IMAGING : 1st quarter earnings
CO
2018EOS IMAGING : Annual results
CO
2018EOS IMAGING SA : annual earnings release
2018EOS IMAGING : announces first system installation within Asklepios Private Hospi..
PU
More news
Financials (EUR)
Sales 2019 44,4 M
EBIT 2019 -3,10 M
Net income 2019 -12,3 M
Debt 2019 2,91 M
Yield 2019 -
P/E ratio 2019 -2,25x
P/E ratio 2020 -4,83x
EV / Sales2019 0,64x
EV / Sales2020 0,82x
Capitalization 25,3 M
Chart EOS IMAGING
Duration : Period :
EOS Imaging Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EOS IMAGING
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 3,30  €
Last Close Price 0,97  €
Spread / Highest target 376%
Spread / Average Target 242%
Spread / Lowest Target 107%
EPS Revisions
Managers
NameTitle
Mike Lobinsky Chief Executive Officer
Gérard Hascoët Chairman
Eric Maulavé Chief Operating Officer
Valérie Worrall Chief Financial Officer
Elisabeth Soubelet Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
EOS IMAGING-71.46%28
THERMO FISHER SCIENTIFIC23.40%109 454
DANAHER CORPORATION36.10%98 416
BOSTON SCIENTIFIC CORPORATION19.27%58 324
INTUITIVE SURGICAL3.45%57 612
EDWARDS LIFESCIENCES CORPORATION43.20%44 757